12th European Conference on Antennas and Propagation (EuCAP 2018) 2018
DOI: 10.1049/cp.2018.0783
|View full text |Cite
|
Sign up to set email alerts
|

Tackling hypertension via adrenal ablation - the development of novel immunohistochemical ablation biomarkers

Abstract: Some of the authors of this publication are also working on these related projects: Non-invasive measurement View project Urinary Bladder Monitoring using Electrical Impedance View project

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 8 publications
(12 reference statements)
0
2
0
Order By: Relevance
“…Existing microwave ablation devices have been clinically applied for treating malignant tumors in the adrenal gland; however, the targeted tumors have typically been large (2.1-6.1 cm) [22][23][24][25]. Technological requirements and feasibility of microwave ablation of adrenal masses were investigated in [26,27]. For actively cooled applicators, adjustment of coolant flow parameters as well as coolant temperature may provide an additional means for adjusting ablation zone length.…”
Section: Introductionmentioning
confidence: 99%
“…Existing microwave ablation devices have been clinically applied for treating malignant tumors in the adrenal gland; however, the targeted tumors have typically been large (2.1-6.1 cm) [22][23][24][25]. Technological requirements and feasibility of microwave ablation of adrenal masses were investigated in [26,27]. For actively cooled applicators, adjustment of coolant flow parameters as well as coolant temperature may provide an additional means for adjusting ablation zone length.…”
Section: Introductionmentioning
confidence: 99%
“…To address these limitations, MWA has emerged as a promising alternative for treating adrenal diseases. MWA uses a needle or stiff catheter to deliver microwave energy to the target area, causing coagulation necrosis by heating the surrounding tissue to temperatures above 50-60 ∘ C [11,12]. MWA offers several theoretical advantages over RFA, such as more precise targeting, efficient ablation, and a reduced risk of complications.…”
Section: Introductionmentioning
confidence: 99%